Dentsply Sirona Appoints Emily P. Miner as Senior Vice President, Quality and Regulatory

Emily P. Miner joins Dentsply Sirona as a proven strategic leader with more than 15 years of quality and regulatory experience in the medical device and pharmaceutical industries.

Simon Campion, Chief Executive Officer of Dentsply Sirona, said, “Emily is a seasoned executive who has acquired significant quality and regulatory experience during her career in major medical device companies. The most critical interface that our customers and their patients have with our company is through the quality of our products, our hardware and our software. Emily’s appointment to the Management Team at Dentsply Sirona is a reflection of our continued commitment to the quality of the products and services we provide to the global dental community.”

Emily P. Miner, Senior Vice President, Quality and Regulatory, said, "I am honored and excited to join the world’s largest dental company where quality and innovation are core values. I am looking forward to working with the team to advance our quality and regulatory initiatives and ensuring that our products and solutions meet the highest standards for our customers globally.”

About Emily P. Miner

With more than 15 years of experience, Emily P. Miner’s expertise spans all elements of Quality and Regulatory management, including Consent Decree remediation, general quality system remediations, extensive global regulatory inspection preparation and management, stage gate development projects, strategic program management, and global quality operations. Most recently, she served as Senior Vice President, Global Quality and Regulatory, at Terumo Cardiovascular since 2018. Prior to Terumo, she was with PwC PRTM Management Consultants, Hospira, and Boston Scientific. Emily holds a Bachelor of Science in Bioengineering from the University of Pittsburgh and a Master of Engineering Management from Duke University.

DISCLAIMER

This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as "may," "could," "estimate," "will," "believe," "anticipate," "think," "intend," "expect," "project," "plan," "target," "forecast", and similar words and expressions. However, these words are not the exclusive means of identifying such statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.